Target intelligence / Profile preview

Streptococcus pneumoniae Type 3 Capsular Polysaccharide (Type 3 CPS)

Target
Type 3 CPS
Molecular classification
Polysaccharide, Capsular Polysaccharide, Antigen
01

Overview

The type 3 capsular polysaccharide (CPS) of Streptococcus pneumoniae is a high-molecular-weight, linear polymer that forms the outermost layer of the bacterial cell. This capsule is a major virulence factor, protecting the bacterium from host immune responses by interfering with opsonophagocytic clearance mechanisms. The repeating unit of type 3 CPS consists of a disaccharide: β-D-glucuronic acid (GlcUA) and β-D-glucose (Glc), linked as [→3)-β-D-GlcUA-(1→4)-β-D-Glc-(1→]. Unlike most other S. pneumoniae capsules, which are covalently attached to peptidoglycan, serotype 3 capsule is anchored non-covalently to phosphatidylglycerol in the cell membrane. Purified type 3 capsular polysaccharide antigen is used in approved vaccines for active immunization against diseases caused by S. pneumoniae serotype 3 strains (including pneumonia and bacteremia).

Other names
S. pneumoniae Type 3 CapsulePneumococcal Type 3 Capsular PolysaccharideCPS3
02

Mechanism of action

Active immunization; antibody production against type 3 CPS to promote opsonophagocytosis and clearance of S. pneumoniae serotype 3.

03

Biological functions

Immune evasionVirulence factorAntigen presentationOpsonophagocytosis inhibition
04

Disease associations

PneumoniaBacteremiaInfection
05

Safety considerations

Serotype-specific immunity (vaccine efficacy limited to serotype 3)Potential for vaccine failure due to serotype replacement
06

Interacting drugs

Pneumovax 23 (vaccine)

1 more in the full profile.

Beyond the preview

Go deeper on Streptococcus pneumoniae Type 3 Capsular Polysaccharide (Type 3 CPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus pneumoniae Type 3 Capsular Polysaccharide (Type 3 CPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call